Sigma 1 Receptor Modulators as a New Weapon Against Multiple Sclerosis

BioDiscovery
doi 10.3897/biodiscovery.20.e14565
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Pensoft Publishers

Related search

Multiple Sclerosis: Longitudinal Measurement of Interleukin-1 Receptor Antagonist.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1997English

New Weapon Promising Against Deadly P. Aeruginosa Strain

Microbe
Microbiology
2010English

A New Method to Synthesize and Optimize Band-Pass Delta-Sigma Modulators

2008English

Systolic Blood Pressure as a Potential Target of Sigma-1 Receptor Agonist Therapy

Journal of Clinical Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

Endothelin-1 Receptor Blockade as New Possible Therapeutic Approach in Multiple Myeloma

British Journal of Haematology
Hematology
2017English

Transient Receptor Potential Vanilloid 1 Modulates Central Inflammation in Multiple Sclerosis

Frontiers in Neurology
Neurology
2019English

Comparisons of Feed-Forward and Multiple-Feedback Sigma-Delta Modulators for MEMS Accelerometers

MATEC Web of Conferences
Materials ScienceEngineeringChemistry
2016English

Colony Stimulation Factor 1 Receptor (CSF1R) Is Not a Common Cause of Multiple Sclerosis

European Journal of Neurology
Neurology
2013English

Orphan Receptor and Chaperon Functions of Sigma-1 Receptor

Folia Pharmacologica Japonica
Pharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy